No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 4.2x · 10Y median 5.5x · 20th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 19
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T22:24:13.691Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T22:24:13.691Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T22:24:13.691Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T22:24:13.691Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T22:24:13.691Z. Latest historical point 2026-10-05.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T22:24:13.691Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T22:24:13.691Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T22:24:13.691Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Waystar Holding Corp. (WAY) stock was $26.40 as of Oct 6, 2026, 4:00 PM EDT, down 0.30% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -31.4%
Waystar Holding Corp. is dedicated to developing a cloud-based software platform designed to streamline financial transactions within the healthcare industry.
Medical - Healthcare Information Services · Lehi, UT
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 4, 2026
29 days away
EPS Estimate
0.41
Revenue Est.
$323.37M
Last Quarter Results
EPS
$0.43
vs Estimate
$0.40
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1WAY | $5.06B | $26.40 | -0.30% | -31.35% | N/A | N/A | N/A |
| 2MMSI | $5.07B | $84.96 | -2.50% | +3.46% | +3.88% | +13.48% | vs WAY |
| 3SRRK | $5.09B | $42.45 | -2.19% | +15.74% | +8.20% | N/A | vs WAY |
| 4ERAS | $4.96B | $14.30 | -2.85% | +503.05% | -8.34% | N/A | vs WAY |
| 5COGT | $5.19B | $30.38 | -1.59% | +95.25% | +28.51% | N/A | vs WAY |
| 6DOCS | $5.20B | $27.79 | -2.76% | -61.83% | -20.25% | N/A | vs WAY |
1.27
$319.67M
vs Estimate
$316.21M
Consensus Rating
Based on 22 analysts
Average Price Target
$33.77
+27.9% upside
Low
$28.00
Current
$26.40
High
$44.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.38 | $0.41 | $0.46 | 12 |
| Quarter ending Dec 2026 | $0.38 | $0.42 | $0.45 | 12 |
| Quarter ending Mar 2027 | $0.44 | $0.45 | $0.45 | 5 |
| Quarter ending Jun 2027 | $0.46 | $0.47 | $0.47 | 5 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $1.60 | $1.67 | $1.74 | 13 |
| FY 2027 | $1.79 | $1.88 | $1.94 | 13 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $317.72M | $323.32M | $333.97M | 12 |
| Quarter ending Dec 2026 | $327.53M | $328.91M | $331.39M | 12 |
| Quarter ending Mar 2027 | $336.91M | $340.81M | $344.57M | 6 |
| Quarter ending Jun 2027 | $345.79M | $349.78M | $353.65M | 6 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $1.28B | $1.29B | $1.30B | 17 |
| FY 2027 | $1.39B | $1.42B | $1.53B | 17 |
